Clinical Trial Update: Hepatoprotective Measures for Children at High Risk of NAFLD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on hepatoprotective measures for children at high risk of nonalcoholic fatty liver disease, including those who are obese/overweig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Nonalcoholic Fatty Liver Disease
• Obesity
• Overweight

Snippet

Sponsor: Ain Shams University | Conditions: Non Alcoholic Fatty Liver Diseases (NAFLD), Obesity and Overweight | Phase 4 | Status: ACTIVE_NOT_RECRUITING